UNSPSC 51284014: Oxytetracycline

This classification denotes a tetracycline antibiotic with the molecular formula C22H24N2O9.2H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier X20I9EN955, chemically known as 2-naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12a-hexahydroxy-6-methyl-1,11-dioxo- but generally known as oxytetracycline, which bears US NIH Compound Identifier 5280972. European Medicines Agency schedules Oxytetracycline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09579MIG.

UNSPSC 51284014 Oxytetracycline is a Commodity code for pharmaceutical supplies, but the recent state and local opportunities tagged under it do not align with oxytetracycline procurement — instead they reflect orders for naloxone, doxycycline hyclate, ciprofloxacin hydrochloride, and drug deactivation systems. State and local governments are using this code inconsistently or the taxonomy assignment does not reflect the actual pharmaceutical products being purchased. The scope of work visible in recent solicitations covers emergency medical countermeasures, broad-spectrum antibiotics, and related health-system supplies procured through both cooperative purchasing agreements and direct competitive bids. Issuing bodies include state health departments and county health authorities, which are leveraging group purchasing consortiums such as MMCAP Infuse to access pre-negotiated pharmaceutical contracts.

Recent activity appears concentrated in Illinois and Florida. The Illinois Department of Public Health awarded a piggyback pharmaceutical contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, totaling $2,999,999.11 over three years, for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets under an Invitation for Bid process — a completed award rather than an open solicitation. Seminole County, Florida released an IFB on June 30, 2026, with a July 26, 2026 response deadline, seeking annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries to the Seminole County Community Health Building in Sanford. The code shows limited recent activity overall, and the misalignment between the nominal commodity and recent awards suggests that bidders pursuing pharmaceutical group purchasing agreements or county health procurements should verify the actual products needed rather than rely on the stated code name.